09.28.20

Aurinia Completes Final Patient Treatment in AUDREY Phase 2/3 Clinical Trial of Voclosporin Ophthalmic Solution for Dry Eye

Source: Aurinia Pharmaceuticals

09.11.20

Kala Pharmaceuticals to Host Key Opinion Leader Symposium on Unmet Need in Dry Eye Disease and Potential for Eysuvis

Source: Kala Pharmaceuticals

09.09.20

Sight Sciences Presents Additional Results of OLYMPIA Study of Signs and Symptoms of Dry Eye Disease Using TearCare

Source: Sight Sciences

08.31.20

Practitioners Should Be Aware of Mask-Associated Dry Eye (MADE)

Source: Centre for Ocular Research & Education

08.31.20

RegeneRx Joint Venture Expects to Complete Phase 3 Dry Eye Trial in November 2020

Source: RegeneRx

07.28.20

New Licensing Agreement Accelerates the Development of IACTA Pharmaceuticals’ Novel Dry Eye Disease and Allergic Conjunctivitis Treatments in China and Southeast Asia

Source: IACTA Pharmaceuticals

07.23.20

Aurinia Prices $200 Million Public Offering of Common Shares

Source: Aurinia Pharmaceuticals

07.21.20

Alcon Survey Shows More Screen Time Causing Consumer Concern About Eye Health, Increasing Symptoms of Dry Eye

Source: Alcon

06.29.20

Novartis Withdraws Marketing Application of Dry Eye Drug Xiidra in Europe

Source: Eyewire News

06.25.20

Topcon Announces the European Launch of MYAH Management Tool for Myopia and Dry Eye

Source: Topcon

View more stories